Table 1. Immunization Composition and Regimen.
Animal | Group | Immunogens | LPSa | IFAb | Immunization Delivery Time (Week) and | |||||||||
Multimeric Protein | DNA | Composition: P = Protein; D = DNA | ||||||||||||
0 | 2 | 4 | 10 | 12 | 20 | 22 | 26 | 32 | ||||||
Rabbit c | 1 | Env(minV3)-E2+Env(V3)-E2 | Env gp160 | + | + | P | P | P | P+D | P+D | P+D | |||
2 | Env(minV3)-E2+Env(V3)-E2 | Env gp160 | + | + | D | D | D | P | P | |||||
3 | Env(minV3)-E2+Env(V3)-E2 | Env gp160 | + | + | P+D | P+D | P+D | P+D | P+D | |||||
4 | Env(minV3)-E2 | Env gp160 | + | + | P+D | P+D | P+D | P+D | P+D | |||||
5 | Env(V3)-E2 | Env gp160 | + | + | P+D | P+D | P+D | P+D | P+D | |||||
6 | Env(V3)-E2 | Env gp160 | − | + | P+D | P+D | P+D | P+D | ||||||
7 | Env(V3)-E2 | Env gp160 | − | − | P+D | P+D | P+D | P+D | ||||||
8 | Env(V3)-E2 | Env gp160 | + | + | P+D | P+D | P+D | P+D | ||||||
Mouse d | 9 | None | Env gp160 | − | − | D | D | |||||||
10 | Env(V3)-E2 | None | + | − | P | P | ||||||||
11 | Env(V3)-E2 | Env gp160 | + | − | P+D | P+D | ||||||||
12 | Env(V3)-E2 | Env gp160 | − | − | P+D | P+D | ||||||||
13 | Unimmunized | None | − | − | − | − |
LPS, lipopolysaccharide.
IFA, Incomplete Freund's adjuvant.
200 µg of E2 intramuscularly (IM) per animal per immunization; 36 µg of codon-optimized HIV-1 SF162 DNA intradermally via Gene Gun.
130 µg of E2 delivered IM; 500 µg (first dose) or 193 µg (second dose) of codon-optimized HIV-1 SF162 DNA was delivered IM.
In all cases blood samples were collected two weeks after each immunization.